LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,449,000 | +6.2% | 75,000 | 0.0% | 3.80% | +8.6% |
| Q2 2021 | $9,839,000 | -13.9% | 75,000 | 0.0% | 3.50% | -28.5% |
| Q1 2021 | $11,434,000 | -53.6% | 75,000 | -69.8% | 4.89% | -56.2% |
| Q4 2020 | $24,667,000 | +4.3% | 248,041 | 0.0% | 11.16% | -19.5% |
| Q3 2020 | $23,644,000 | -22.6% | 248,041 | -9.2% | 13.87% | -16.8% |
| Q2 2020 | $30,540,000 | +19.0% | 273,041 | -22.7% | 16.67% | +2.9% |
| Q1 2020 | $25,673,000 | -30.3% | 353,041 | 0.0% | 16.20% | +8.6% |
| Q4 2019 | $36,819,000 | +4.8% | 353,041 | 0.0% | 14.92% | +1.1% |
| Q3 2019 | $35,141,000 | -12.8% | 353,041 | 0.0% | 14.76% | -13.2% |
| Q2 2019 | $40,299,000 | -6.8% | 353,041 | +2.6% | 17.00% | -1.4% |
| Q1 2019 | $43,250,000 | -7.4% | 344,041 | 0.0% | 17.24% | -21.4% |
| Q4 2018 | $46,686,000 | -50.6% | 344,041 | 0.0% | 21.94% | -28.4% |
| Q3 2018 | $94,436,000 | +32.5% | 344,041 | 0.0% | 30.64% | +14.7% |
| Q2 2018 | $71,275,000 | -22.0% | 344,041 | -37.8% | 26.72% | -29.0% |
| Q1 2018 | $91,340,000 | -12.6% | 553,041 | -27.5% | 37.65% | -9.4% |
| Q4 2017 | $104,470,000 | -3.9% | 762,944 | -4.4% | 41.55% | -10.5% |
| Q3 2017 | $108,661,000 | -10.3% | 798,100 | -20.0% | 46.45% | -8.2% |
| Q2 2017 | $121,170,000 | +14.7% | 998,100 | 0.0% | 50.58% | -0.5% |
| Q1 2017 | $105,639,000 | +4.2% | 998,100 | 0.0% | 50.83% | -0.4% |
| Q4 2016 | $101,417,000 | -0.4% | 998,100 | 0.0% | 51.04% | -2.9% |
| Q3 2016 | $101,866,000 | -99.9% | 998,100 | -16.8% | 52.58% | +59.5% |
| Q2 2016 | $143,096,091,000 | +11.4% | 1,199,766 | 0.0% | 32.96% | -3.7% |
| Q1 2016 | $128,482,941,000 | -1.2% | 1,199,766 | 0.0% | 34.23% | -4.0% |
| Q4 2015 | $130,078,630,000 | +26.6% | 1,199,766 | 0.0% | 35.65% | +20.3% |
| Q3 2015 | $102,759,958,000 | -18.5% | 1,199,766 | -4.0% | 29.64% | +13.6% |
| Q2 2015 | $126,101,389,000 | +30.9% | 1,249,766 | 0.0% | 26.08% | +25.7% |
| Q1 2015 | $96,369,456,000 | +44.9% | 1,249,766 | 0.0% | 20.76% | +32.4% |
| Q4 2014 | $66,500,049,000 | +13.2% | 1,249,766 | 0.0% | 15.68% | +40.3% |
| Q3 2014 | $58,726,504,000 | -24.6% | 1,249,766 | 0.0% | 11.17% | -19.9% |
| Q2 2014 | $77,847,923,000 | -7.4% | 1,249,766 | 0.0% | 13.96% | -13.2% |
| Q1 2014 | $84,071,759,000 | +23.7% | 1,249,766 | -3.3% | 16.07% | +15.9% |
| Q4 2013 | $67,988,972,000 | +21.5% | 1,292,566 | 0.0% | 13.87% | +29.7% |
| Q3 2013 | $55,942,256,000 | +3.0% | 1,292,566 | -11.0% | 10.70% | -5.4% |
| Q2 2013 | $54,325,968,000 | – | 1,452,566 | – | 11.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |